The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

People with Parkinson’s disease may also experience cognitive changes and struggle with day-to-day activities. Research is ongoing about the specific components of Parkinson’s disease and what actions ...

Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...

CINCINNATI (WKRC) - A new wearable drug delivery device made by Enable Injections in Evendale could soon help change the lives of those living with a progressive disorder that impacts the nervous ...

A late-stage trial of Cerevel Therapeutic’s Parkinson’s disease drug showed a significant reduction in the time patients suffer from symptoms, the company said Thursday, the latest study indicating ...

An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...